Clinical trial
Zevalin and BEAM High-dose Chemotherapy Compared With BEAM Alone as Conditioning…
NCT00463463 · Soroka University Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00463463 |
|---|---|
| Title | Zevalin and BEAM High-dose Chemotherapy Compared With BEAM Alone as Conditioning Regimen in Patients With Chemosensitive Relapse of Non-Hodgkin's Lymphoma |
| Official title | Phase III Stidy of Zevalin And BEAM Compared With BEAM Alone Prior to Autologous Hematopoietic Steem Cell Transpl. in Pts Relapse of Non-Hodgkins Lymphoma |
| Acronym | Zevalin |
| Lead sponsor | Soroka University Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma |
| Intervention type | Drug |
| Interventions | 90Yttrium Ibritumomab Tiuxetan (Zevalin) |
| Start date | Apr 1, 2007 |
| First posted | Apr 20, 2007 |
| Last update posted | Jul 12, 2012 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: